Machina Capital S.A.S. Takes $1.31 Million Position in Cardinal Health, Inc. $CAH

Machina Capital S.A.S. purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 7,774 shares of the company’s stock, valued at approximately $1,306,000.

Other hedge funds have also recently bought and sold shares of the company. Principal Financial Group Inc. increased its stake in shares of Cardinal Health by 5.3% in the first quarter. Principal Financial Group Inc. now owns 315,817 shares of the company’s stock valued at $43,510,000 after purchasing an additional 15,956 shares during the period. KLP Kapitalforvaltning AS grew its holdings in Cardinal Health by 4.0% in the 2nd quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after buying an additional 4,400 shares in the last quarter. Czech National Bank increased its position in Cardinal Health by 5.1% in the 2nd quarter. Czech National Bank now owns 58,341 shares of the company’s stock valued at $9,801,000 after acquiring an additional 2,857 shares during the period. Zurich Insurance Group Ltd FI raised its stake in Cardinal Health by 4,935.9% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after acquiring an additional 927,950 shares in the last quarter. Finally, Accurate Wealth Management LLC boosted its position in Cardinal Health by 92.8% during the 2nd quarter. Accurate Wealth Management LLC now owns 3,627 shares of the company’s stock worth $588,000 after acquiring an additional 1,746 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Insider Activity at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares in the company, valued at $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the sale, the chief executive officer owned 26,085 shares in the company, valued at $3,881,969.70. This represents a 61.45% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 271,676 shares of company stock valued at $40,489,525 over the last ninety days. Company insiders own 0.12% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH opened at $190.22 on Tuesday. The firm’s 50 day moving average is $156.05 and its 200-day moving average is $155.04. Cardinal Health, Inc. has a 12-month low of $110.63 and a 12-month high of $197.67. The stock has a market capitalization of $45.19 billion, a P/E ratio of 29.49, a P/E/G ratio of 1.39 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm’s revenue for the quarter was up 22.4% compared to the same quarter last year. During the same period last year, the firm posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date was Wednesday, October 1st. Cardinal Health’s payout ratio is presently 30.77%.

Analyst Ratings Changes

A number of brokerages have recently commented on CAH. UBS Group raised their price target on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a report on Friday. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Leerink Partners upped their price target on shares of Cardinal Health from $187.00 to $211.00 in a research note on Friday. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Finally, TD Cowen boosted their target price on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a report on Monday. Eleven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $200.54.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.